Piper Sandler Highlights Intuitive Surgical (ISRG) on Long-Term Growth Catalysts

Intuitive Surgical, Inc. (NASDAQ:ISRG) ranks among the best set-it-and-forget-it stocks to buy right now. On June 2, Piper Sandler restated its Overweight rating and $580 target on Intuitive Surgical, Inc. (NASDAQ:ISRG). The firm’s recent field check with the head of robotics at a prominent U.S. healthcare institution confirmed the firm’s positive opinion of the company. The hospital system has significant expertise with Intuitive Surgical’s da Vinci system, notably the DV5 model, as well as other robotic solutions.

The field check focused on issues regarding the long-term viability of US volume growth, third-party equipment reprocessing, and increasing competition.

Piper Sandler recognized many growth catalysts for Intuitive Surgical, Inc. (NASDAQ:ISRG), such as the ambulatory surgery center possibility, DV5 cardiovascular treatments, and My Intuitive+. The firm claimed it is convinced the basic fundamentals of the company remain solid and that prevailing concerns are blown out of proportion.

In addition, Intuitive Surgical, Inc. (NASDAQ:ISRG) recently announced upgrades to its da Vinci 5 robotic surgical system, which include improved Intuitive Telepresence and longer tool use, which is expected to be ready in June, subject to regulatory clearance.

Intuitive Surgical, Inc. (NASDAQ:ISRG) engages in the development, manufacturing, and marketing of da Vinci surgical systems and the Ion endoluminal system.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.